{
  "id": 15556759,
  "title": "T-MAXIMUM's B7-H3-Targeted Allogeneic CAR-T MT027 Receives FDA Clearance for Phase 2 Study",
  "url": "https://urgent.news/2026/10/19/t-maximums-b7-h3-targeted-allogeneic-car-t-mt027-receives-fda",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-19T03:56:40.000Z",
  "source": {
    "name": "Antara News Indonesia",
    "slug": "antara-news-indonesia",
    "url": "https://en.antaranews.com/news/436365/t-maximums-b7-h3-targeted-allogeneic-car-t-mt027-receives-fda-clearance-for-phase-2-study"
  },
  "original_language": "en",
  "account": null,
  "summary": "T-MAXIMUM PHARMACEUTICAL (\"T-MAXIMUM\") today announced that the U.S. Food and Drug Administration (FDA) has ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}